SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $71,037 | -39.8% | 40,362 | +7.5% | 0.00% | 0.0% |
| Q4 2022 | $117,904 | -29.0% | 37,549 | +10.8% | 0.00% | -50.0% |
| Q3 2022 | $166,000 | +19.4% | 33,883 | +1.0% | 0.00% | +100.0% |
| Q2 2022 | $139,000 | -28.4% | 33,556 | +0.3% | 0.00% | -50.0% |
| Q1 2022 | $194,000 | -22.1% | 33,471 | +0.7% | 0.00% | 0.0% |
| Q4 2021 | $249,000 | -17.0% | 33,249 | -0.2% | 0.00% | 0.0% |
| Q3 2021 | $300,000 | -24.2% | 33,313 | +0.6% | 0.00% | -33.3% |
| Q2 2021 | $396,000 | -9.8% | 33,099 | -5.4% | 0.00% | -25.0% |
| Q1 2021 | $439,000 | -19.2% | 34,998 | +0.7% | 0.00% | -20.0% |
| Q4 2020 | $543,000 | +59.2% | 34,770 | -3.8% | 0.01% | +66.7% |
| Q3 2020 | $341,000 | +45.7% | 36,132 | +38.1% | 0.00% | 0.0% |
| Q2 2020 | $234,000 | +35.3% | 26,168 | -3.9% | 0.00% | 0.0% |
| Q1 2020 | $173,000 | – | 27,218 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 916,153 | $8,740,000 | 1.27% |
| Casdin Capital, LLC | 1,080,000 | $10,303,000 | 1.13% |
| Rhenman & Partners Asset Management AB | 843,957 | $8,051,000 | 0.94% |
| WASATCH ADVISORS LP | 6,437,908 | $61,418,000 | 0.67% |
| BB BIOTECH AG | 2,650,000 | $25,281,000 | 0.64% |
| Trellus Management Company, LLC | 30,000 | $286,000 | 0.54% |
| Opus Point Partners Management, LLC | 33,529 | $320,000 | 0.43% |
| SECTOR GAMMA AS | 238,857 | $2,279,000 | 0.36% |
| Leisure Capital Management | 37,656 | $359,000 | 0.30% |
| Ceeto Capital Group, LLC | 41,000 | $391,000 | 0.29% |